- Report
- March 2024
- 191 Pages
Global
From €3277EUR$3,374USD£2,800GBP
€3641EUR$3,749USD£3,111GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- February 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- January 2024
- 190 Pages
Global
From €4759EUR$4,900USD£4,066GBP
- Report
- February 2021
- 420 Pages
United States
From €2331EUR$2,400USD£1,991GBP
- Report
- June 2018
- 155 Pages
Global
From €607EUR$625USD£519GBP
€1214EUR$1,250USD£1,037GBP
- Report
- August 2022
- 120 Pages
Global
From €4613EUR$4,750USD£3,941GBP
- Report
- August 2022
- 122 Pages
Global
From €4613EUR$4,750USD£3,941GBP
- Report
- August 2022
- 30 Pages
Global
From €3157EUR$3,250USD£2,697GBP
- Report
- January 2022
- 205 Pages
Global
From €7284EUR$7,500USD£6,223GBP
- Report
- April 2023
- 116 Pages
Global
From €4759EUR$4,900USD£4,066GBP
- Report
- June 2018
- 103 Pages
Global
From €10679EUR$10,995USD£9,123GBP
- Report
- April 2018
Global
From €971EUR$1,000USD£830GBP
- Report
- August 2022
- 170 Pages
Global
From €3496EUR$3,600USD£2,987GBP
- Report
- January 2021
- 138 Pages
China, Global
From €3000EUR$3,309USD£2,653GBP
- Report
- July 2022
- 109 Pages
Global
From €1942EUR$2,000USD£1,660GBP
- Report
- May 2024
- 50 Pages
Global
From €2574EUR$2,650USD£2,199GBP
- Report
- November 2021
- 844 Pages
Global
From €4856EUR$5,000USD£4,149GBP
Modafinil is a central nervous system (CNS) drug used to treat excessive sleepiness caused by narcolepsy, shift work sleep disorder, and obstructive sleep apnea. It is also used off-label to treat attention deficit hyperactivity disorder (ADHD), depression, and cognitive enhancement. Modafinil is a stimulant drug that works by increasing the release of dopamine in the brain, which helps to improve alertness, focus, and concentration. It is considered to be a safe and effective treatment for excessive sleepiness, with few side effects.
The modafinil market is growing rapidly, driven by the increasing prevalence of sleep disorders and the growing demand for cognitive enhancement drugs. The market is expected to be further driven by the increasing awareness of the benefits of modafinil and the increasing availability of generic versions of the drug.
Some companies in the modafinil market include Cephalon, Sun Pharmaceuticals, Teva Pharmaceuticals, Mylan, and Intas Pharmaceuticals. Show Less Read more